Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Liu Zi, Wencheng Zhou, Jiake Xu, Junshu Li, Ning Li, Jianguo Xu, Chao You, Chengwei Wang & Meng Tian. (2021) Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage. International Journal of Nanomedicine 16, pages 2933-2947.
Read now
Read now
Roshna Roy, Architha Ajithan, Anisa Joseph, Uday Venkat Mateti & Subramanyam K. (2019) Statin-induced new onset of diabetes in dyslipidemic patients: a retrospective study. Postgraduate Medicine 131:6, pages 383-387.
Read now
Read now
Steven G. Chrysant. (2018) Authors reply: statins and new onset of diabetes: which one outweighs risk or benefit?. Postgraduate Medicine 130:1, pages 147-147.
Read now
Read now
Articles from other publishers (32)
Vikram Mehraj, Jun Chen & Jean-Pierre Routy. (2024) Effects of statins beyond lipid-lowering agents in ART-treated HIV infection. Frontiers in Immunology 15.
Crossref
Crossref
Valentina Anelli, Eleni Armeni, Stavroula A. Paschou & Irene Lambrinoudaki. (2024) Statin use and incident type 2 diabetes mellitus in women after menopause. Maturitas 181, pages 107914.
Crossref
Crossref
Yulin Yang, Xiaolin Wang, Yongchao Wang, Hao Xu & Jian Li. (2023) SGLT2 inhibitors can reduce the incidence of abnormal blood glucose caused by statins in non-diabetes patients with HFrEF after PCI. BMC Cardiovascular Disorders 23:1.
Crossref
Crossref
Mehwish Tayyab, Adnan Jehangir, Farhana Ayub, Nimra Ijaz, Sameer Ahmed` & Attiya Munir. (2023) Anti-Hyperlipidemic Effect of Zinc complex of Betulinic acid in High Fat Diet- Induced Hyperlipidemia. Journal of Rawalpindi Medical College 27:1.
Crossref
Crossref
Felicia Liana Andronie-Cioară, Anamaria Jurcău, Maria Carolina Jurcău, Delia Carmen Nistor-Cseppentö & Aurel Simion. (2022) Cholesterol Management in Neurology: Time for Revised Strategies?. Journal of Personalized Medicine 12:12, pages 1981.
Crossref
Crossref
Enrica Rossini, Federico Biscetti, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Marcello Covino, Antonio Gasbarrini, Massimo Massetti & Andrea Flex. (2022) Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?. International Journal of Molecular Sciences 23:16, pages 9326.
Crossref
Crossref
Sun-Kyoung Park, Ji-Hye Lee, Ho-Sik Hwang, Hyun-Seung Kim, Kyung-Do Han & Kyung-Sun Na. (2022) Association of Meibomian Gland Dysfunction with Oral Statin Use. Journal of Clinical Medicine 11:15, pages 4632.
Crossref
Crossref
Jia-Ling Lin, Po-Sheng Chen, Hui-Wen Lin, Liang-Miin TsaiSheng-Hsiang Lin & Yi-Heng Li. (2022) Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study. Journal of Atherosclerosis and Thrombosis 29:8, pages 1213-1225.
Crossref
Crossref
Jyotsna Needamangalam Balaji, Sreenidhi Prakash, Ashish Joshi & Krishna Mohan Surapaneni. (2022) A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy. Clinics and Practice 12:4, pages 565-578.
Crossref
Crossref
Yuliang Chai, Yuanqing Liu, Ruijuan Yang, Maobin Kuang, Jiajun Qiu & Yang Zou. (2022) Association of body mass index with risk of prediabetes in Chinese adults: A population‐based cohort study. Journal of Diabetes Investigation 13:7, pages 1235-1244.
Crossref
Crossref
Ferran Trias, Xavier Pintó, Emili Corbella, Manuel Suárez-Tembra, Antonio Ruíz-García, José Luis Díaz-Díaz, Elena Sánchez-Ruíz-Granado, Itziar Sarasa, Raul Martínez-Porqueras, Maria Angeles Rodríguez-Sánchez & Xavier Corbella. (2022) Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study. Medicina Clínica 158:11, pages 531-539.
Crossref
Crossref
Ferran Trias, Xavier Pintó, Emili Corbella, Manuel Suárez-Tembra, Antonio Ruíz-García, José Luis Díaz-Díaz, Elena Sánchez-Ruíz-Granado, Itziar Sarasa, Raul Martínez-Porqueras, Maria Angeles Rodríguez-Sánchez & Xavier Corbella. (2022) Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study. Medicina Clínica (English Edition) 158:11, pages 531-539.
Crossref
Crossref
Harmanjit Singh, Pallavi Sikarwar, Supreet Khurana & Jatin Sharma. (2022) Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses. European Endocrinology 18:2, pages 96.
Crossref
Crossref
Juyoung Shin, Hyunah Kim, Hyeon Woo Yim, Ju Han Kim, Suehyun Lee & Hun‐Sung Kim. (2021) Angiotensin‐converting enzyme inhibitors versus angiotensin receptor blockers: New‐onset diabetes mellitus stratified by statin use. Journal of Clinical Pharmacy and Therapeutics 47:1, pages 97-103.
Crossref
Crossref
S. G. Dzugkoev, O. Yu. Garmash & F. S. Dzugkoeva. (2021) Pathogenetic rationale for using an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and an antioxidant coenzyme Q<sub>10</sub> in the treatment and prevention of cardiovascular disease. Cardiovascular Therapy and Prevention 20:6, pages 2793.
Crossref
Crossref
Dinesh Gyawali, Rini Vohra, David Orme-Johnson, Sridharan Ramaratnam & Robert H. Schneider. (2021) A Systematic Review and Meta-Analysis of Ayurvedic Herbal Preparations for Hypercholesterolemia. Medicina 57:6, pages 546.
Crossref
Crossref
Corinna Dannecker, Robert Wagner, Andreas Peter, Julia Hummel, Andreas Vosseler, Hans-Ulrich Häring, Andreas Fritsche, Andreas L Birkenfeld, Norbert Stefan & Martin Heni. (2021) Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion. The Journal of Clinical Endocrinology & Metabolism 106:6, pages 1576-1584.
Crossref
Crossref
Toke de Koning Svendsen, Thomas Krøigård, Martin Wirenfeldt, Henrik Daa Schrøder, Søren Bak, Sören Möller, Jesper Hallas, Søren Hein Sindrup & David Gaist. (2019) Statin use and peripheral nerve function—A prospective follow‐up study. Basic & Clinical Pharmacology & Toxicology 126:3, pages 203-211.
Crossref
Crossref
Fotios Barkas, Evangelos Liberopoulos & Evangelos C. Rizos. (2020) Author’s Reply. Journal of Cardiology 75:2, pages 217.
Crossref
Crossref
Linglin Qian, Kongbo Zhu, Yanshan Lin, Li An, Feiyang Huang, Yuyu Yao & Liqun Ren. (2019) Insulin secretion impairment induced by rosuvastatin partly though autophagy in INS‐1E cells. Cell Biology International 44:1, pages 127-136.
Crossref
Crossref
Yin-Huei Chen, Yu-Cih Yang, Weishan Chen, Yen-Nien Lin & Yi-Chih Hung. (2019) Risk of macrovascular complications in statin-treated patients developing diabetes. Diabetes Research and Clinical Practice 157, pages 107870.
Crossref
Crossref
Elisenda Climent, David Benaiges & Juan Pedro-Botet. (2019) Statin treatment and increased diabetes risk. Possible mechanisms. Clínica e Investigación en Arteriosclerosis 31:5, pages 228-232.
Crossref
Crossref
Elisenda Climent, David Benaiges & Juan Pedro-Botet. (2019) Statin treatment and increased diabetes risk. Possible mechanisms. Clínica e Investigación en Arteriosclerosis (English Edition) 31:5, pages 228-232.
Crossref
Crossref
Maryam Paseban, Alexandra E. Butler & Amirhossein Sahebkar. (2019) Mechanisms of statin‐induced new‐onset diabetes. Journal of Cellular Physiology 234:8, pages 12551-12561.
Crossref
Crossref
Robert K. Naviaux. (2019) Metabolic features and regulation of the healing cycle—A new model for chronic disease pathogenesis and treatment. Mitochondrion 46, pages 278-297.
Crossref
Crossref
Niki Katsiki & Dimitri P Mikhailidis. (2018) Lipids: a personal view of the past decade. Hormones 17:4, pages 461-478.
Crossref
Crossref
V. Z. Lankin, A. K. Tikhaze & G. G. Konovalova. (2018) THE INFLUENCE OF HYPOLIPIDEMIC THERAPY ON THE LEVEL OF MODIFIED LOW DENSITY LIPOPROTEIDES. Russian Journal of Cardiology:8, pages 39-44.
Crossref
Crossref
Tsung-Kun Lin, Pesus Chou, Ching-Heng Lin, Yi-Jen Hung & Gwo-Ping Jong. (2018) Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study. PLOS ONE 13:5, pages e0196713.
Crossref
Crossref
Massa Oi, Daniel Donner, Jason Peart, Belinda Beck, Lauren Wendt, John P. Headrick & Eugene F. du Toit. (2018) Pravastatin improves risk factors but not ischaemic tolerance in obese rats. European Journal of Pharmacology 826, pages 148-157.
Crossref
Crossref
Niki Katsiki, Athanasios D Giannoukas, Vasilios G Athyros & Dimitri P Mikhailidis. (2018) Lipid-lowering treatment in peripheral artery disease. Current Opinion in Pharmacology 39, pages 19-26.
Crossref
Crossref
Yoshihide Yamanashi, Tappei Takada & Hiroshi Suzuki. (2018) Associations between Lifestyle-Related Diseases and Transporters Involved in Intestinal Absorption and Biliary Excretion of Cholesterol. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 41:1, pages 1-10.
Crossref
Crossref
Leliang Li, Ping Li, Juan Yang, Xiao Huang, Huihui Bao, Chunyan Zhang, Yun Song, Min Zhao, Meng Ji, Yi Wang, Geng Qian, Genfu Tang, Shanqun Jiang, Qiang Dong, Yan Zhang, Jianping Li, Xiping Xu, Binyan Wang, Yong Huo & Xiaoshu Cheng. (2017) Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial. Scientific Reports 7:1.
Crossref
Crossref